10.02.17
The Society of Cosmetic Chemists has scheduled CEP courses in connection with its upcoming Annual Scientific Meeting and Technology Showcase including “Safety Assessment as a Tool for Global Compliance of Cosmetic Products and their Ingredients,” and “Claim Substantiation for Cosmetic Products,” both of which will be held Dec. 10 from (9am-5pm) at The Westin New York at Times Square.
The safety assessment workshop, moderated by Steven L. Hanft of CONUSBAT Regulatory Services, will provide attendees with knowledge on the current industry regulations by delivering the following information through presentations and panel discussions: requirements for a cosmetic ingredient and cosmetic product safety assessment; necessary data to support the safety of the ingredients and the product; hazard characterization and exposure assessment; and establishing a cosmetic product safety report as legal document for proof of liability and for global market access. Attendees will learn the FDA requirements for establishing the safety of cosmetics, be updated on EU’s Cosmetics Product Safety Report, and understand the individual safety assessment—addressing raw materials, ingredients, impurities. Speakers will include Karl Popp, R.Ph.; KPopp Consulting LLC; Craig R. Weiss, Consumer Product Testing Company; Dr. Uwe Rossow, CCR GmbH & Co. KG; and Dr. Annelie Struessmann; CONUSBAT Regulatory Services.
Dr. Nava Dayan of Dr. Nava Dayan, LLC will be the instructor for “Claim Substantiation for Cosmetic Products.” The FDA and the FTC are carefully watching cosmetic products for non-substantiated, misleading claims. If the claim is indeed misleading the consumer and drives to a purchase of a product that will not deliver its premise, it becomes an ethical matter. With the skin care industry striving to produce safer products, it should also further stream its scientific resources toward testing products for their activity on the skin and provide fair translation into claims. Common criteria for justification of claims are a challenging aspect in product development since it needs to be customized for the purpose of use and nature of the product developed. This course is tailored to provide key aspects in the establishment of best practice to be applied in experimental design and tie it into the regulatory framework rationale. It will focus on recent developments in skin biomarkers research and skin microbiome as well as human clinical studies.
More info: www.scconline.org
The safety assessment workshop, moderated by Steven L. Hanft of CONUSBAT Regulatory Services, will provide attendees with knowledge on the current industry regulations by delivering the following information through presentations and panel discussions: requirements for a cosmetic ingredient and cosmetic product safety assessment; necessary data to support the safety of the ingredients and the product; hazard characterization and exposure assessment; and establishing a cosmetic product safety report as legal document for proof of liability and for global market access. Attendees will learn the FDA requirements for establishing the safety of cosmetics, be updated on EU’s Cosmetics Product Safety Report, and understand the individual safety assessment—addressing raw materials, ingredients, impurities. Speakers will include Karl Popp, R.Ph.; KPopp Consulting LLC; Craig R. Weiss, Consumer Product Testing Company; Dr. Uwe Rossow, CCR GmbH & Co. KG; and Dr. Annelie Struessmann; CONUSBAT Regulatory Services.
Dr. Nava Dayan of Dr. Nava Dayan, LLC will be the instructor for “Claim Substantiation for Cosmetic Products.” The FDA and the FTC are carefully watching cosmetic products for non-substantiated, misleading claims. If the claim is indeed misleading the consumer and drives to a purchase of a product that will not deliver its premise, it becomes an ethical matter. With the skin care industry striving to produce safer products, it should also further stream its scientific resources toward testing products for their activity on the skin and provide fair translation into claims. Common criteria for justification of claims are a challenging aspect in product development since it needs to be customized for the purpose of use and nature of the product developed. This course is tailored to provide key aspects in the establishment of best practice to be applied in experimental design and tie it into the regulatory framework rationale. It will focus on recent developments in skin biomarkers research and skin microbiome as well as human clinical studies.
More info: www.scconline.org
